Results 81 to 90 of about 9,597 (210)

Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia

Human Vaccines & Immunotherapeutics, 2018
Shanchol™, a WHO-prequalified oral cholera vaccine (OCV), has been used to control endemic cholera in Asia, as well as in emergencies and outbreaks elsewhere.
Samuel Teshome, Sachin Desai, Jerome H. Kim, Dires Belay, Vittal Mogasale   +4 more
doaj   +1 more source

Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers

Vaccines, 2020
Cholera is endemic in approximately 50 countries, primarily in Africa and South and Southeast Asia, and in these areas, it remains a disease associated with poverty.
Giovanni Gabutti, Andrea Rossanese, Alberto Tomasi, Sandro Giuffrida, Vincenzo Nicosia, Juan Barriga, Caterina Florescu, Federica Sandri, Armando Stefanati   +8 more
doaj   +1 more source

Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. [PDF]

PLoS Neglected Tropical Diseases, 2014
The substantial morbidity and mortality associated with recent cholera outbreaks in Haiti and Zimbabwe, as well as with cholera endemicity in countries throughout Asia and Africa, make a compelling case for supplementary cholera control measures in ...
Shantanu K Kar, Binod Sah, Bikash Patnaik, Yang Hee Kim, Anna S Kerketta, Sunheang Shin, Shyam Bandhu Rath, Mohammad Ali, Vittal Mogasale, Hemant K Khuntia, Anuj Bhattachan, Young Ae You, Mahesh K Puri, Anna Lena Lopez, Brian Maskery, Gopinath B Nair, John D Clemens, Thomas F Wierzba   +17 more
doaj   +1 more source

Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines

Vox Sanguinis, Volume 121, Issue 7, Page 923-926, July 2026.
Pierre Tiberghien, Pierre Gallian, Virginie de La Taille, Caroline Bacquet, Syria Laperche   +4 more
wiley   +1 more source

Engineered Probiotics: The Next‐Generation Therapeutics to Combat Antibiotic‐Resistant Bacterial Infections

Food Frontiers, Volume 7, Issue 2, March 2026.
Engineered probiotics secretes fusion proteins which potentially neutralized the toxins secreted by other microbial communities. ABSTRACT On a global scale, the escalating burden of infectious diseases, predominantly attributed to bacterial pathogens, especially drug‐resistant strains, has progressed into a critical concern for clinical management and ...
Indu Singh, Raz Abdulqadir, Indira Kumari Verma, Yashika Awasthi, Arun Ratn, Juhi Sharma, Manmeet Rawat, Megh Singh Dhakad, Jasbir Dalal, Yash Gupta, Bhisham Narayan Singh, Divakar Sharma   +11 more
wiley   +1 more source

Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012 [PDF]

, 2013
During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response.
Sakoba, Kéïta, Melatwork Haile (446457), Luquero, Francisco J., Luquero Francisco J., Iza Ciglenecki (446458), Haile Melatwork, Sylla, Souleymane, Melatwork Haile, Isabel Martinez-Pino (446454), Souleymane Sylla (446456), Quilici Marie-Laure, Francisco J. Luquero, Isabel Martinez-Pino, Ciglenecki Iza, Rebecca F Grais, Sylla Souleymane, Grais Rebecca F., Francisco J Luquero, Haile, Melatwork, Kéïta Sakoba (446455), Kéïta Sakoba, Grais, Rebecca, Francisco J. Luquero (121649), Luquero, Francisco J, Page, Anne-Laure, Ciglenecki, Iza, Souleymane Sylla, Anne-Laure Page, Quilici, Marie-Laure, Grais, Rebecca F, Rebecca F. Grais, Martinez-Pino, Isabel, Iza Ciglenecki, Page Anne-Laure, Marie-Laure Quilici, Anne-Laure Page (247439), Martinez-Pino Isabel, Rebecca F. Grais (38515), Sakoba Kéïta, Marie-Laure Quilici (320927)   +39 more
core   +1 more source

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa, Agness Shimilimo, Olivier Uwishema, Helen Onyeaka   +3 more
wiley   +1 more source

Allocation of Oral Cholera Vaccines in Africa

Vaccines
Objectives: In this study, we examine the allocation of oral cholera vaccines (OCVs) across 25 African countries between 2013 and 2019. Methods: We constructed a dataset combining cholera outbreaks and requests, decisions, and deliveries of OCVs from the Global Task Force on Cholera Control, alongside additional covariates.
Elisa M. Maffioli, Yutong Lu
openaire   +3 more sources

Vaccines against cholera, typhoid fever and shigellosis for developing countries. [PDF]

, 2004
Enteric diseases, such as cholera, typhoid fever and shigellosis, still produce a significant burden, especially among the poor in countries where these illnesses are endemic.
Ochiai, RL, Deen, JL, Lee, HJ, Acosta, CJ, von Seidlein, L, Galindo, CM, Carbis, R, Clemens, JD   +7 more
core   +1 more source

Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial [PDF]

, 2020
Antibody avidity is an important measure of the quality of vaccine-induced immune responses. Murine and human studies suggest that antibody avidity may be augmented by limiting access to antigen.
Mottram, Lynda,, Lundgren, Anna,, Svennerholm, Ann-Mari,, Leach, Susannah,   +3 more
core   +1 more source